Aleos Capital
Also known as Aleos Capital SGEIC SA, Aleos Capital, S.G.E.I.C., S.A.
Madrid lower mid-market private equity manager in life sciences (CNMV reg. 234, 2025); debut Aleos Fund I first close above €150m, €15–25m tickets in Iberian SMEs.
- HEADQUARTERS
- Madrid, Spain
- FOUNDED
- —
- AUM
- —
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 3 people
Focus
- STAGES
- GrowthBuyout
- ASSET MIX
- Private equity
- GEOGRAPHY
- SpainPortugal
Overview
Aleos Capital SGEIC was entered in the CNMV register in February 2025 and is led by Héctor Ciria, former CEO of Quirónsalud and ex-Principal at Apax Partners, and David Santos, former partner at Alantra Private Equity. Its debut fund, Aleos Fund I, invests in Spanish and Portuguese companies in health and wellbeing, sustainable nutrition, and climate and environment, with EBITDA of €2m–€8m, through majority or significant minority stakes of €15m–€25m. Press reported a first close above €150m with a €240m hard cap, from institutional investors and family offices.
Investment thesis
Lower mid-market buy-and-build and growth investments in profitable Iberian life-sciences SMEs (health and wellbeing, sustainable nutrition, climate and environment), using international expansion, sector consolidation, management strengthening, sustainability and technology as value levers.
People
Frequently asked questions
Aleos Capital is a private equity fund based in Madrid, Spain.
Yes. Aleos Capital invests its own capital in private companies.
Aleos Capital invests at Growth and Buyout stages in HealthTech, Biotech & Life Sciences, Food & Agriculture and Climate & Energy.
Aleos Capital's stated ticket size is €15M–€25M.
Key people at Aleos Capital include Héctor Ciria (Co-founder), David Santos (Co-founder) and Daniel Aymerich (Management team).
Yes. Aleos Capital manages capital from outside investors.